Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $3.83 and traded as low as $3.54. Ampliphi Biosciences shares last traded at $3.72, with a volume of 105,069 shares changing hands.
Ampliphi Biosciences Stock Up 4.0%
The business has a 50 day moving average price of $3.83 and a two-hundred day moving average price of $6.83.
About Ampliphi Biosciences
AmpliPhi Biosciences was a clinical-stage biotechnology company developing bacteriophage-based therapies for bacterial infections, including infections caused by antibiotic-resistant bacteria. Bacteriophages are viruses that target and infect specific bacteria, and the company pursued them as a potential complement or alternative to conventional antibiotics. Its investigational programs included AB-PA01, a bacteriophage cocktail targeting Pseudomonas aeruginosa, and AB-SA01, aimed at Staphylococcus aureus.
Further Reading
- Five stocks we like better than Ampliphi Biosciences
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
